From Placental Pathophysiology to Practice: Advancing Preeclampsia Risk Assessment with Angiogenic Biomarkers

Course overview

Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality worldwide, placing a significant burden on families and healthcare systems. Despite its adverse impact, accurate detection has long been a challenge. This educational webinar will explore how sFlt-1 and PlGF can help support more effective clinical decision-making to improve patient outcomes. Join Dr. Stefan Verlohren, a leading expert in maternal-fetal medicine, as he provides an overview of the development and progression of preeclampsia. He will then examine through case study examples how the sFlt-1/PlGF ratio (PE ratio) is used in different clinical settings to assess risk and manage patients. In addition, Dr. Verlohren will explain how the different clinical utilities of the PE ratio are used in a holistic, integrated approach for helping to improve outcomes for both mother and baby. Designed for lab professionals and clinicians, this webinar will highlight the critical role of laboratory diagnostics in providing more effective preeclampsia patient care.